Andrew T. Chan, MD, MPH is a gastroenterologist, the Daniel K. Podolsky Professor of Medicine at Harvard Medical School, Professor of Immunology and Infectious Diseases at Harvard T. H. Chan School of Public Health, Chief of the Clinical and Translational Epidemiology Unit at Massachusetts General Hospital and the Director of Epidemiology at the MGH Cancer Center. Dr. Chan is an international expert in cancer prevention and interception, leading several seminal studies examining the role of aspirin, diet, and the gut microbiome on cancer risk. He is supported as an Outstanding Investigator of the National Cancer Institute, Team Leader for the Stand Up to Cancer Gastric Cancer Interception Team, and by grants from the National Institute for Diabetes and Digestive and Kidney Diseases and the National Institute on Aging. An elected member of the American Society for Clinical Investigation and the Association of American Physicians, he has published over 500 papers in leading journals, including NEJM, JAMA, Lancet, Science, Nature Medicine, Gastroenterology and Gut. Dr. Chan is a section editor for Gastroenterology, and serves on the editorial board of JNCI, Cancer Prevention Research, Cancer Epidemiology Biomarkers and Prevention. He is the Clinical Research Councillor of the AGA and chair of the Population Sciences Working Group of the American Association for Cancer Research (AACR).
Sign up to be part of the aspirin community and be the first to receive latest information.
Have something to say about aspirin?